Andrew D Schechtman, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Offices
- 3
Offices
3 locations · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Schechtman’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G80004 · Current
Licensed to practise in California · since 1994 · expires 2028-10-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$31,963
Medicare paid this office $31,963 for 71 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 51 | $13,231 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $3,521 | $153 |
| Sarscov2 vac 50 mcg/0.5ml im | 15 | $2,682 | $149 |
| Long return visit (40+ min) | 12 | $1,727 | $123 |
| Influenza vaccine split virus, preservative free | 15 | $1,289 | $81 |
See all 8 services
| Return visit (30+ min) | 51 | $13,231 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $3,521 | $153 |
| Sarscov2 vac 50 mcg/0.5ml im | 15 | $2,682 | $149 |
| Long return visit (40+ min) | 12 | $1,727 | $123 |
| Influenza vaccine split virus, preservative free | 15 | $1,289 | $81 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 41 | $1,268 | $13 |
| Admn sarscov2 vacc 1 dose | 15 | $938 | $52 |
| Administration of influenza virus vaccine | 16 | $650 | $38 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
71 Original Medicare patients in 2024. Average age 76 · Women 44% · Also on Medicaid 17% · Health risk score 1.35. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Coronary heart disease 34% · Diabetes 28% · Depression 21% · Chronic kidney disease 20% · Atrial fibrillation 20% · Heart failure 18% · Cancer 17%.
The office billed $112,058, Medicare allowed $41,327 and paid $31,963; for 409 services of 33 kinds; $4,869 of it was for drugs given in the office and $27,094 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 71 | 409 | 76 | 1.35 | $112,058 | $31,963 |
| 2023 | 119 | 349 | 75 | 2.26 | $135,431 | $36,392 |
| 2022 | 114 | 369 | 76 | 1.83 | $138,218 | $37,986 |
| 2021 | 133 | 418 | 75 | 2.01 | $161,055 | $44,007 |
| 2020 | 132 | 408 | 74 | 2.16 | $155,617 | $36,649 |
| 2019 | 168 | 544 | 74 | 1.98 | $190,848 | $44,907 |
| 2018 | 79 | 229 | 75 | 1.57 | $76,428 | $20,046 |
| 2017 | 123 | 296 | 75 | 2.22 | $96,176 | $24,724 |
| 2016 | 175 | 497 | 74 | 2.21 | $158,237 | $41,940 |
| 2015 | 149 | 412 | 73 | 2.03 | $117,388 | $36,266 |
| 2014 | 185 | 457 | 73 | 1.67 | $113,115 | $36,824 |
| 2013 | 225 | 573 | 75 | 2.35 | $108,958 | $50,622 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $8,217 | $107 |
| Return visit (30+ min) | 45 | $7,918 | $108 |
| Long return visit (40+ min) | 17 | $4,344 | $150 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $3,906 | $156 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,339 | $156 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,951 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,753 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,542 | $64 |
| Short return visit (20+ min) | 16 | $1,161 | $73 |
2022: 7 services
| Return visit (30+ min) | 48 | $10,061 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $6,130 | $88 |
| Long return visit (40+ min) | 18 | $4,865 | $174 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,705 | $174 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 20 | $3,171 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,065 | $61 |
| Hospital discharge day management, 30 minutes or less | 25 | $1,660 | $66 |
2021: 8 services
| Return visit (30+ min) | 48 | $10,824 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $7,684 | $97 |
| Long return visit (40+ min) | 18 | $6,256 | $165 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,947 | $192 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,945 | $164 |
| Hospital discharge day management, 30 minutes or less | 35 | $2,237 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,817 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,368 | $124 |
2020: 7 services
| Return visit (30+ min) | 48 | $7,959 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,419 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $6,042 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,305 | $68 |
| Hospital discharge day management, 30 minutes or less | 33 | $2,292 | $69 |
| Short return visit (20+ min) | 19 | $1,787 | $60 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,450 | $73 |
2019: 11 services
| Return visit (30+ min) | 66 | $13,832 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,238 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $4,054 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,911 | $66 |
| Hospital discharge day management, 30 minutes or less | 34 | $2,509 | $68 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,485 | $118 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,700 | $142 |
| Influenza vaccine split virus, preservative free | 17 | $980 | $54 |
| Short return visit (20+ min) | 15 | $892 | $56 |
| Administration of influenza virus vaccine | 19 | $410 | $21 |
| Administration of pneumococcal vaccine | 16 | $328 | $21 |
2018: 3 services
| Return visit (30+ min) | 39 | $6,205 | $95 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,825 | $140 |
| Administration of pneumococcal vaccine | 12 | $309 | $26 |
2017: 6 services
| Return visit (30+ min) | 38 | $5,124 | $70 |
| Hospital discharge day management, 30 minutes or less | 41 | $2,783 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,757 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,721 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,685 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,792 | $90 |
2016: 10 services
| Return visit (30+ min) | 53 | $10,977 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,030 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $4,758 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $4,352 | $93 |
| Hospital discharge day management, 30 minutes or less | 48 | $3,156 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,308 | $121 |
| Pneumococcal vaccine, 13-valent | 11 | $1,929 | $175 |
| Influenza vaccine split virus, preservative free | 12 | $500 | $38 |
| Administration of influenza virus vaccine | 14 | $475 | $32 |
| Administration of pneumococcal vaccine | 13 | $412 | $32 |
2015: 9 services
| Return visit (30+ min) | 54 | $11,633 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,959 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,925 | $96 |
| Hospital discharge day management, 30 minutes or less | 42 | $2,889 | $69 |
| Pneumococcal vaccine, 13-valent | 14 | $2,263 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,734 | $67 |
| Short return visit (20+ min) | 15 | $947 | $63 |
| Administration of influenza virus vaccine | 15 | $540 | $32 |
| Administration of pneumococcal vaccine | 16 | $507 | $32 |
2014: 10 services
| Return visit (30+ min) | 42 | $9,232 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $6,004 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,036 | $180 |
| Hospital discharge day management, 30 minutes or less | 50 | $3,271 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $3,010 | $61 |
| Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day at least 70 minutes | 17 | $2,329 | $137 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,190 | $122 |
| Short return visit (20+ min) | 17 | $1,041 | $61 |
| Administration of influenza virus vaccine | 21 | $685 | $31 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 21 | $260 | $12 |
2013: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $11,765 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $11,493 | $174 |
| Return visit (30+ min) | 35 | $7,850 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $5,505 | $63 |
| Hospital discharge day management, 30 minutes or less | 76 | $5,005 | $64 |
| Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day at least 70 minutes | 20 | $2,841 | $142 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,745 | $119 |
| Short return visit (20+ min) | 17 | $941 | $52 |
Medicaid work
$78,416 in 2024
Medicaid paid $78,416 for 702 billed services this clinician did in 2024, up to 57 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 297 | $74,778 |
| Short return visit (20+ min) | 320 | $2,464 |
| Return visit (30+ min) | 85 | $1,173 |
| 2024 | 702 | 3 | 57 | $78,416 |
| 2023 | 646 | 3 | 71 | $74,866 |
| 2022 | 576 | 3 | 52 | $57,137 |
| 2021 | 2,576 | 6 | 171 | $235,614 |
| 2020 | 2,018 | 10 | 141 | $190,644 |
| 2019 | 1,714 | 8 | 119 | $188,674 |
| 2018 | 614 | 3 | 109 | $89,018 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 305 | $73,967 |
| Short return visit (20+ min) | 283 | $643 |
| Return visit (30+ min) | 58 | $257 |
2022
| Clinic visit/encounter, all-inclusive | 239 | $55,362 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 31 | $962 |
| Short return visit (20+ min) | 306 | $813 |
2021
| Clinic visit/encounter, all-inclusive | 969 | $227,426 |
| Short return visit (20+ min) | 963 | $2,421 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 151 | $2,172 |
| 1ST HOSP IP/OBS HIGH 75 | 44 | $1,594 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 61 | $1,141 |
| Short return visit | 388 | $860 |
2020
| Clinic visit/encounter, all-inclusive | 809 | $186,202 |
| Short return visit (20+ min) | 799 | $1,959 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 26 | $623 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 31 | $571 |
| Short return visit | 211 | $561 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $552 |
| Return visit (30+ min) | 31 | $96 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 26 | $80 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 51 | $0 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 21 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 816 | $184,961 |
| Short return visit (20+ min) | 617 | $1,965 |
| Short return visit | 164 | $673 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 26 | $491 |
| TD VACC NO PRESV 7 YRS+ IM | 12 | $321 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 36 | $165 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 26 | $85 |
| Bilateral quantitative screening test of visual acuity | 17 | $13 |
2018
| Clinic visit/encounter, all-inclusive | 390 | $87,480 |
| Short return visit (20+ min) | 212 | $1,522 |
| Short return visit | 12 | $16 |
Drugs they prescribed that Part D paid
$135,062
Pharmacies billed $135,062 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 6% of their Part D prescriptions (60 of 987) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
848 generic and fewer than 11 brand-name prescriptions · $135,062 in drug cost · 15 antibiotic prescriptions to 13 people · 23 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 23 | $27,521 | $1,197 |
| Potassium Chloride | 14 | $531 | $38 |
| Oxycodone | 28 | $491 | $18 |
| Levothyroxine | 41 | $457 | $11 |
| Quetiapine | 15 | $443 | $30 |
See all 24 drugs
| Jardiance | 23 | $27,521 | $1,197 |
| Potassium Chloride | 14 | $531 | $38 |
| Oxycodone | 28 | $491 | $18 |
| Levothyroxine | 41 | $457 | $11 |
| Quetiapine | 15 | $443 | $30 |
| Hydrocodone-Acetaminophen | 15 | $406 | $27 |
| Atorvastatin | 60 | $385 | $6 |
| Losartan | 24 | $367 | $15 |
| Amlodipine Besylate | 56 | $358 | $6 |
| Pravastatin | 35 | $337 | $10 |
| Fluticasone Propionate | 13 | $326 | $25 |
| Tamsulosin | 22 | $324 | $15 |
| Rosuvastatin | 19 | $253 | $13 |
| Olmesartan Medoxomil | 15 | $229 | $15 |
| Omeprazole | 14 | $219 | $16 |
| Escitalopram | 11 | $185 | $17 |
| Lisinopril | 32 | $184 | $6 |
| Metformin | 18 | $140 | $8 |
| Alendronate | 16 | $127 | $8 |
| Triamcinolone Acetonide | 14 | $93 | $7 |
| Ondansetron | 12 | $92 | $8 |
| Trazodone | 14 | $61 | $4 |
| Sertraline | 11 | $41 | $4 |
| Furosemide | 11 | $38 | $3 |
Year by year
| 2024 | 987 | 111 | 6% (60) | None | $135,062 |
| 2023 | 1,139 | 121 | 7% (75) | None | $165,788 |
| 2022 | 1,247 | 115 | 6% (74) | None | $137,779 |
| 2021 | 1,226 | 154 | 6% (67) | None | $89,149 |
| 2020 | 1,085 | 183 | 4% (40) | None | $64,921 |
| 2019 | 961 | 138 | 7% (65) | None | $56,388 |
| 2018 | 361 | 86 | 7% (25) | None | $13,951 |
| 2017 | 859 | 124 | 5% (40) | None | $52,162 |
| 2016 | 1,456 | 171 | 4% (64) | 15% | $71,291 |
| 2015 | 1,166 | 163 | 8% (91) | 15% | $61,286 |
| 2014 | 1,030 | 134 | 7% (75) | None | $48,803 |
| 2013 | 1,264 | 131 | 6% (71) | None | $51,162 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Jardiance | 20 | $35,874 | $1,794 |
| Ozempic | 13 | $11,818 | $909 |
| Myrbetriq | 13 | $9,124 | $702 |
| Spiriva Handihaler | 13 | $8,340 | $642 |
| Trelegy Ellipta | 12 | $7,320 | $610 |
| Tamsulosin | 26 | $1,052 | $40 |
| Levothyroxine | 56 | $955 | $17 |
| Atorvastatin | 64 | $849 | $13 |
| Oxycodone | 25 | $799 | $32 |
| Pravastatin | 45 | $740 | $16 |
| Potassium Chloride | 11 | $671 | $61 |
| Hydrocodone-Acetaminophen | 22 | $542 | $25 |
| Losartan | 22 | $484 | $22 |
| Omeprazole | 20 | $479 | $24 |
| Rosuvastatin | 21 | $453 | $22 |
| Amlodipine Besylate | 59 | $440 | $7 |
| Olmesartan Medoxomil | 11 | $430 | $39 |
| Sertraline | 18 | $422 | $23 |
| Metformin | 34 | $395 | $12 |
| Duloxetine | 12 | $348 | $29 |
| Pantoprazole | 15 | $305 | $20 |
| Diclofenac | 13 | $302 | $23 |
| Lisinopril | 31 | $273 | $9 |
| Clopidogrel | 12 | $268 | $22 |
| Trazodone | 19 | $234 | $12 |
| Donepezil | 12 | $211 | $18 |
| Ondansetron | 19 | $201 | $11 |
| Metformin Hcl Er | 13 | $187 | $14 |
| Meloxicam | 11 | $74 | $7 |
| Tramadol | 12 | $53 | $4 |
| Hydrochlorothiazide | 12 | $45 | $4 |
2022: 33 drugs
| Trulicity | 16 | $21,228 | $1,327 |
| Jardiance | 24 | $21,175 | $882 |
| Eliquis | 20 | $16,971 | $849 |
| Ozempic | 13 | $11,540 | $888 |
| Spiriva Handihaler | 13 | $7,011 | $539 |
| Entresto | 11 | $6,727 | $612 |
| Levothyroxine | 70 | $1,319 | $19 |
| Pravastatin | 46 | $872 | $19 |
| Atorvastatin | 58 | $849 | $15 |
| Potassium Chloride | 11 | $678 | $62 |
| Oxycodone | 25 | $662 | $26 |
| Losartan | 27 | $622 | $23 |
| Olmesartan Medoxomil | 11 | $561 | $51 |
| Albuterol Sulfate Hfa | 13 | $506 | $39 |
| Amlodipine Besylate | 59 | $468 | $8 |
| Sertraline | 18 | $377 | $21 |
| Omeprazole | 29 | $368 | $13 |
| Tamsulosin | 17 | $364 | $21 |
| Lisinopril | 35 | $336 | $10 |
| Ondansetron | 20 | $322 | $16 |
| Rosuvastatin | 19 | $315 | $17 |
| Metformin | 31 | $313 | $10 |
| Hydrocodone-Acetaminophen | 30 | $312 | $10 |
| Fluticasone Propionate | 18 | $293 | $16 |
| Alendronate | 15 | $236 | $16 |
| Metoprolol | 12 | $215 | $18 |
| Fluoxetine | 16 | $214 | $13 |
| Pantoprazole | 16 | $189 | $12 |
| Metformin Hcl Er | 11 | $147 | $13 |
| Clopidogrel | 15 | $146 | $10 |
| Allopurinol | 12 | $122 | $10 |
| Furosemide | 13 | $116 | $9 |
| Hydrochlorothiazide | 13 | $28 | $2 |
2021: 34 drugs
| Trulicity | 17 | $13,945 | $820 |
| Eliquis | 17 | $13,567 | $798 |
| Trelegy Ellipta | 12 | $6,920 | $577 |
| Levothyroxine | 85 | $1,741 | $20 |
| Buprenorphine-Naloxone | 16 | $1,137 | $71 |
| Pravastatin | 54 | $849 | $16 |
| Potassium Chloride | 13 | $824 | $63 |
| Atorvastatin | 63 | $779 | $12 |
| Amlodipine Besylate | 66 | $689 | $10 |
| Hydrocodone-Acetaminophen | 27 | $510 | $19 |
| Fluoxetine | 30 | $473 | $16 |
| Albuterol Sulfate Hfa | 11 | $470 | $43 |
| Chlorthalidone | 11 | $453 | $41 |
| Metoprolol | 17 | $419 | $25 |
| Losartan | 26 | $406 | $16 |
| Fluticasone Propionate | 17 | $395 | $23 |
| Omeprazole | 28 | $379 | $14 |
| Tamsulosin | 16 | $378 | $24 |
| Lisinopril | 38 | $301 | $8 |
| Rosuvastatin | 15 | $276 | $18 |
| Pantoprazole | 13 | $250 | $19 |
| Metformin | 32 | $247 | $8 |
| Sertraline | 20 | $218 | $11 |
| Clopidogrel | 18 | $214 | $12 |
| Benazepril | 15 | $205 | $14 |
| Trazodone | 13 | $201 | $15 |
| Furosemide | 16 | $173 | $11 |
| Oxycodone | 12 | $107 | $9 |
| Tramadol | 16 | $90 | $6 |
| Ondansetron | 11 | $80 | $7 |
| Zolpidem | 14 | $75 | $5 |
| Triamcinolone Acetonide | 11 | $70 | $6 |
| Oxycodone-Acetaminophen | 11 | $62 | $6 |
| Hydrochlorothiazide | 11 | $22 | $2 |
2020: 29 drugs
| Eliquis | 13 | $5,628 | $433 |
| Breo Ellipta | 11 | $4,212 | $383 |
| Bystolic | 24 | $3,831 | $160 |
| Levothyroxine | 64 | $1,812 | $28 |
| Potassium Chloride | 34 | $1,319 | $39 |
| Pravastatin | 51 | $1,155 | $23 |
| Atorvastatin | 49 | $728 | $15 |
| Losartan | 38 | $621 | $16 |
| Fluticasone Propionate | 22 | $531 | $24 |
| Sildenafil Citrate | 12 | $497 | $41 |
| Albuterol Sulfate Hfa | 11 | $494 | $45 |
| Amlodipine Besylate | 52 | $417 | $8 |
| Metoprolol | 18 | $415 | $23 |
| Lisinopril | 50 | $407 | $8 |
| Furosemide | 33 | $368 | $11 |
| Rosuvastatin | 16 | $354 | $22 |
| Hydrocodone-Acetaminophen | 19 | $291 | $15 |
| Omeprazole | 25 | $273 | $11 |
| Lorazepam | 19 | $270 | $14 |
| Tamsulosin | 14 | $260 | $19 |
| Metformin | 22 | $203 | $9 |
| Sertraline | 11 | $173 | $16 |
| Trazodone | 12 | $156 | $13 |
| Pantoprazole | 17 | $138 | $8 |
| Triamcinolone Acetonide | 12 | $106 | $9 |
| Hydrochlorothiazide | 17 | $79 | $5 |
| Simvastatin | 11 | $78 | $7 |
| Tramadol | 14 | $73 | $5 |
| Prednisone | 11 | $47 | $4 |
2019: 26 drugs
| Bystolic | 19 | $2,867 | $151 |
| Levothyroxine | 44 | $1,242 | $28 |
| Pravastatin | 48 | $1,183 | $25 |
| Potassium Chloride | 22 | $914 | $42 |
| Tamsulosin | 11 | $681 | $62 |
| Chlorthalidone | 12 | $635 | $53 |
| Fluticasone Propionate | 23 | $553 | $24 |
| Oxycodone-Acetaminophen | 17 | $456 | $27 |
| Rosuvastatin | 14 | $449 | $32 |
| Hydrocodone-Acetaminophen | 19 | $445 | $23 |
| Omeprazole | 23 | $433 | $19 |
| Atorvastatin | 18 | $393 | $22 |
| Metoprolol | 17 | $337 | $20 |
| Furosemide | 29 | $314 | $11 |
| Metformin | 26 | $307 | $12 |
| Lisinopril | 31 | $291 | $9 |
| Fluoxetine | 14 | $283 | $20 |
| Losartan | 26 | $268 | $10 |
| Amlodipine Besylate | 32 | $244 | $8 |
| Pantoprazole | 16 | $183 | $11 |
| Triamcinolone Acetonide | 16 | $120 | $7 |
| Tramadol | 16 | $98 | $6 |
| Eszopiclone | 15 | $81 | $5 |
| Clonidine | 14 | $62 | $4 |
| Lorazepam | 15 | $50 | $3 |
| Hydrochlorothiazide | 13 | $45 | $3 |
2018: 8 drugs
| Pravastatin | 19 | $481 | $25 |
| Levothyroxine | 15 | $447 | $30 |
| Atorvastatin | 14 | $348 | $25 |
| Omeprazole | 13 | $313 | $24 |
| Hydrocodone-Acetaminophen | 11 | $295 | $27 |
| Lisinopril | 14 | $152 | $11 |
| Losartan | 12 | $126 | $10 |
| Lorazepam | 11 | $33 | $3 |
2017: 23 drugs
| Lantus | 11 | $7,869 | $715 |
| Raloxifene | 15 | $1,871 | $125 |
| Pravastatin | 43 | $1,056 | $25 |
| Levothyroxine | 32 | $980 | $31 |
| Hydrocodone-Acetaminophen | 21 | $855 | $41 |
| Atorvastatin | 38 | $615 | $16 |
| Omeprazole | 35 | $540 | $15 |
| Potassium Chloride | 11 | $480 | $44 |
| Fluticasone Propionate | 28 | $416 | $15 |
| Tamsulosin | 16 | $366 | $23 |
| Lisinopril | 38 | $239 | $6 |
| Warfarin | 20 | $155 | $8 |
| Pantoprazole | 15 | $133 | $9 |
| Amlodipine Besylate | 21 | $124 | $6 |
| Levetiracetam | 13 | $122 | $9 |
| Lorazepam | 30 | $113 | $4 |
| Furosemide | 24 | $108 | $4 |
| Losartan | 14 | $107 | $8 |
| Atenolol | 13 | $102 | $8 |
| Simvastatin | 14 | $90 | $6 |
| Quetiapine | 12 | $89 | $7 |
| Hydrochlorothiazide | 18 | $55 | $3 |
| Metoprolol | 16 | $51 | $3 |
2016: 36 drugs
| Lantus | 19 | $10,104 | $532 |
| Pravastatin | 83 | $2,305 | $28 |
| Raloxifene | 15 | $2,091 | $139 |
| Hydrocodone-Acetaminophen | 33 | $1,533 | $46 |
| Levothyroxine | 48 | $1,295 | $27 |
| Oxycodone-Acetaminophen | 13 | $959 | $74 |
| Atorvastatin | 63 | $836 | $13 |
| Chlorthalidone | 14 | $710 | $51 |
| Tamsulosin | 22 | $634 | $29 |
| Omeprazole | 41 | $609 | $15 |
| Lisinopril | 65 | $513 | $8 |
| Nortriptyline | 11 | $407 | $37 |
| Amlodipine Besylate | 70 | $366 | $5 |
| Pantoprazole | 39 | $362 | $9 |
| Fluoxetine | 19 | $348 | $18 |
| Metformin | 35 | $344 | $10 |
| Insulin | 13 | $292 | $22 |
| Fluticasone Propionate | 23 | $287 | $12 |
| Lorazepam | 26 | $281 | $11 |
| Ibuprofen | 15 | $254 | $17 |
| Simvastatin | 37 | $212 | $6 |
| Furosemide | 49 | $200 | $4 |
| Atenolol | 25 | $194 | $8 |
| Levetiracetam | 14 | $193 | $14 |
| Losartan | 21 | $190 | $9 |
| Warfarin | 19 | $187 | $10 |
| Gabapentin | 13 | $165 | $13 |
| Allopurinol | 15 | $159 | $11 |
| Metoprolol | 20 | $122 | $6 |
| Hydrochlorothiazide | 19 | $87 | $5 |
| Quetiapine | 11 | $80 | $7 |
| Escitalopram | 13 | $68 | $5 |
| Glipizide | 17 | $58 | $3 |
| Risperidone | 12 | $54 | $5 |
| Donepezil | 13 | $41 | $3 |
| Metformin Hcl Er | 11 | $37 | $3 |
2015: 29 drugs
| Pravastatin | 88 | $2,612 | $30 |
| Evista | 12 | $2,404 | $200 |
| Hydrocodone-Acetaminophen | 49 | $2,151 | $44 |
| Oxycodone-Acetaminophen | 26 | $1,680 | $65 |
| Tamsulosin | 25 | $1,430 | $57 |
| Levothyroxine | 38 | $1,122 | $30 |
| Proair Hfa | 13 | $865 | $67 |
| Oxybutynin Chloride | 14 | $837 | $60 |
| Atorvastatin | 37 | $618 | $17 |
| Fenofibrate | 14 | $600 | $43 |
| Omeprazole | 38 | $479 | $13 |
| Chlorthalidone | 12 | $437 | $36 |
| Amlodipine Besylate | 51 | $301 | $6 |
| Lisinopril | 49 | $284 | $6 |
| Pantoprazole | 28 | $245 | $9 |
| Atenolol | 23 | $237 | $10 |
| Metformin | 30 | $228 | $8 |
| Alendronate | 13 | $196 | $15 |
| Nortriptyline | 14 | $196 | $14 |
| Losartan | 20 | $189 | $9 |
| Furosemide | 33 | $185 | $6 |
| Lovastatin | 18 | $154 | $9 |
| Risperidone | 11 | $128 | $12 |
| Hydrochlorothiazide | 33 | $126 | $4 |
| Simvastatin | 13 | $118 | $9 |
| Fluticasone Propionate | 11 | $118 | $11 |
| Warfarin | 11 | $113 | $10 |
| Sertraline | 13 | $103 | $8 |
| Paroxetine | 14 | $89 | $6 |
2014: 21 drugs
| Patanol | 14 | $2,258 | $161 |
| Oxycodone-Acetaminophen | 29 | $1,764 | $61 |
| Pravastatin | 56 | $1,674 | $30 |
| Hydrocodone-Acetaminophen | 26 | $1,214 | $47 |
| Tamsulosin | 23 | $783 | $34 |
| Levothyroxine | 35 | $680 | $19 |
| Lisinopril | 62 | $442 | $7 |
| Amlodipine Besylate | 62 | $404 | $7 |
| Pantoprazole | 31 | $334 | $11 |
| Atorvastatin | 17 | $323 | $19 |
| Fluticasone Propionate | 14 | $285 | $20 |
| Lovastatin | 17 | $247 | $15 |
| Omeprazole | 25 | $227 | $9 |
| Glipizide | 18 | $179 | $10 |
| Atenolol | 23 | $159 | $7 |
| Simvastatin | 19 | $148 | $8 |
| Hydrochlorothiazide | 27 | $124 | $5 |
| Warfarin | 12 | $107 | $9 |
| Losartan | 16 | $102 | $6 |
| Furosemide | 24 | $79 | $3 |
| Paroxetine | 11 | $62 | $6 |
2013: 29 drugs
| Celebrex | 15 | $2,501 | $167 |
| Evista | 12 | $2,197 | $183 |
| Patanol | 12 | $1,646 | $137 |
| Pravastatin | 79 | $1,394 | $18 |
| Renvela | 12 | $1,068 | $89 |
| Atorvastatin | 29 | $716 | $25 |
| Oxycodone Hcl-Acetaminophen | 18 | $619 | $34 |
| Tamsulosin | 32 | $594 | $19 |
| Levothyroxine | 53 | $589 | $11 |
| Amlodipine Besylate | 87 | $589 | $7 |
| Oxybutynin Chloride | 15 | $512 | $34 |
| Lisinopril | 72 | $487 | $7 |
| Omeprazole | 36 | $384 | $11 |
| Risperidone | 16 | $358 | $22 |
| Warfarin | 16 | $324 | $20 |
| Hydrocodone-Acetaminophen | 35 | $319 | $9 |
| Synthroid | 11 | $304 | $28 |
| Pantoprazole | 20 | $260 | $13 |
| Lovastatin | 16 | $244 | $15 |
| Sertraline | 22 | $239 | $11 |
| Prazosin | 11 | $229 | $21 |
| Metformin | 27 | $206 | $8 |
| Atenolol | 36 | $200 | $6 |
| Simvastatin | 23 | $188 | $8 |
| Losartan-Hydrochlorothiazide | 13 | $186 | $14 |
| Ibuprofen | 13 | $126 | $10 |
| Hydrochlorothiazide | 27 | $121 | $4 |
| Furosemide | 40 | $121 | $3 |
| Metoprolol | 14 | $69 | $5 |
Money from drug and device companies
$36 in 2025
A payment is not proof that care is biased.
| Pfizer | Prevnar 20 | $36 | 1 payment
|
See the published payment
| Pfizer | Meals · 2025-12-04 | Prevnar 20 | $36 |
Professional record
- NPI
- 1881770428
- Licence
- CA G80004California G80004: Current · expires 2028-10-31
- Trained
- University of California, Geffen School of Medicine, 1993
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 455 Oconnor Dr, Suite 210, San Jose, CA, 95128
- NPI first listed
- 2006-10-27
- NPI last updated
- 2012-01-25
This is when the NPI record was last certified, not a medical board exam.